Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 7498546)

Published in FEBS Lett on December 04, 1995

Authors

A Kanai1, K Tanabe, M Kohara

Author Affiliations

1: Department of Microbiology, Tokyo Metropolitan Institute of Medical Science, Rinshoken, Japan.

Articles citing this

Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J Virol (2002) 2.62

Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77

Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J Virol (1999) 1.67

Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62

3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol (2007) 1.62

Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol (1998) 1.54

Visualizing ATP-dependent RNA translocation by the NS3 helicase from HCV. J Mol Biol (2010) 1.38

Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties. J Virol (2003) 1.31

Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol (1997) 1.25

Understanding helicases as a means of virus control. Curr Pharm Des (2006) 1.18

Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA. J Virol (2001) 1.15

RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog (2010) 1.10

Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome. J Virol (2013) 0.91

Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein. J Virol (2013) 0.90

Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA (2004) 0.88

EWSR1 binds the hepatitis C virus cis-acting replication element and is required for efficient viral replication. J Virol (2013) 0.86

Aptamers in diagnostics and treatment of viral infections. Viruses (2015) 0.80

The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation. Sci Rep (2016) 0.80

Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp. PLoS One (2012) 0.78

Oligonucleotide aptamers: potential novel molecules against viral hepatitis. Res Pharm Sci (2017) 0.75

Articles by these authors

(truncated to the top 100)

Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14

Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94

Complete genomic sequence of the filamentous nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120. DNA Res (2001) 4.27

Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med (2001) 4.19

Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88

Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83

The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology (2001) 3.25

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98

Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55

Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol (1999) 2.46

Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44

Role of the unfolded protein response in cell death. Apoptosis (2006) 2.39

Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28

In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26

Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19

Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16

Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem (1998) 2.04

The native form and maturation process of hepatitis C virus core protein. J Virol (1998) 1.91

Current status of organ transplantation in Japan. Am J Transplant (2011) 1.89

Determination of functional domains in polypyrimidine-tract-binding protein. Biochem J (1998) 1.63

Physical and genetic mapping of the Salmonella dublin virulence plasmid pSDL2. Relationship to plasmids from other Salmonella strains. J Clin Invest (1988) 1.63

An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61

Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology (1999) 1.60

Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology (1994) 1.60

Chick embryo DNA polymerase alpha. Polypeptide components and their microheterogeneity. J Biol Chem (1982) 1.57

Characterization of rabies viruses recovered from persistently infected BHK cells. Virology (1975) 1.47

N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K). Clin Pharmacol Ther (2012) 1.45

Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B. J Biol Chem (2000) 1.43

Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. Exp Parasitol (2001) 1.41

Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology (1997) 1.40

LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. Biochem J (2001) 1.40

Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region. Infect Immun (1999) 1.40

Henoch-Schönlein purpura in an elderly patient with unusual manifestation. Endoscopy (2007) 1.39

A second group of hepatitis C viruses. Virus Genes (1991) 1.39

Amplification by polymerase chain reaction of Plasmodium falciparum DNA from Giemsa-stained thin blood smears. Mol Biochem Parasitol (1995) 1.35

Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res (1991) 1.34

Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation (1997) 1.32

Phylogenetic association of Pneumocystis carinii with the 'Rhizopoda/Myxomycota/Zygomycota group' indicated by comparison of 5S ribosomal RNA sequences. Mol Biochem Parasitol (1989) 1.29

Steady-state kinetics of mouse DNA polymerase beta. Biochemistry (1979) 1.28

Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase. J Biol Chem (1997) 1.27

Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates. Mol Biochem Parasitol (1993) 1.26

Theoretical analyses on the role of Mg2+ ions in ribozyme reactions. FASEB J (1993) 1.24

Interallelic recombination in the merozoite surface protein 1 (MSP-1) gene of Plasmodium vivax from Thai isolates. Mol Biochem Parasitol (1997) 1.24

Two new types of C-band variants in human chromosome (6ph+ and 12ph+). Jinrui Idengaku Zasshi (1974) 1.24

Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transplant (1999) 1.23

Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene (1999) 1.21

Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation. Diabetologia (2008) 1.20

Regulation and interplay of apoptotic and non-apoptotic cell death. J Pathol (2006) 1.20

Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods (1996) 1.20

Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut (1996) 1.18

Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry (1989) 1.18

Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period. Am J Transplant (2011) 1.17

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti (supplement). DNA Res (2000) 1.17

Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther (2006) 1.17

Stable patterns of allelic diversity at the Merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from southern Vietnam. J Eukaryot Microbiol (1998) 1.16

A method for monitoring the viability of malaria parasites (Plasmodium yoelii) freed from the host erythrocytes. Trans R Soc Trop Med Hyg (1987) 1.16

Necropsy findings in HTLV-I associated myelopathy. Lancet (1987) 1.16

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation (2002) 1.16

Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia (2010) 1.15

Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation (2000) 1.15

Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant (2009) 1.13

Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Exp Parasitol (1997) 1.12

Cloning and sequencing of the gene encoding the large subunit of glutathione synthetase of Schizosaccharomyces pombe. Biochem Biophys Res Commun (1991) 1.12

Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc (1996) 1.12

Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy. Cancer Gene Ther (2006) 1.10

Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem (1998) 1.09

Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. Am J Trop Med Hyg (1994) 1.09

Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol Res (2001) 1.08

A new Thermus-Escherichia coli shuttle integration vector system. J Bacteriol (1997) 1.08

Serological observations of Pneumocystis carinii infection in humans. J Clin Microbiol (1985) 1.07

Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population. J Viral Hepat (2005) 1.07

Purification and characterization of adipose tissue S-100b protein. J Biol Chem (1983) 1.06

Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J Biol Chem (2001) 1.05

Structural homology of DNA polymerase beta from various mammalian cells. J Biol Chem (1981) 1.05

The occurrence of three different proteoglycan species in chick embryo cartilage. Isolation and characterization of a second proteoglycan (PG-Lb) and its precursor form. J Biol Chem (1983) 1.04

Cloning of a Ca(2+)-ATPase gene of Plasmodium falciparum and comparison with vertebrate Ca(2+)-ATPases. J Cell Sci (1993) 1.04

Protein kinase C phosphorylation of desmin at four serine residues within the non-alpha-helical head domain. J Biol Chem (1989) 1.04

Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case report. Jpn Circ J (2000) 1.03

Strategy for construction of live picornavirus vaccines. Vaccine (1988) 1.03

Allelic diversity at the merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from the southwestern Brazilian Amazon. Am J Trop Med Hyg (1998) 1.03

Preliminary trial of adjuvant surgery for advanced gastric cancer. Oncol Lett (2010) 1.03

Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia (2009) 1.02

Allelic diversity in the merozoite surface protein-1 and epidemiology of multiple-clone Plasmodium falciparum infections in northern Tanzania. J Parasitol (1998) 1.01

Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat (2002) 1.01

Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes. Diabetes (2001) 1.00

Iridium complex-catalyzed allylic amination of allylic esters. J Am Chem Soc (2001) 1.00

Calcium transport of Plasmodium chabaudi-infected erythrocytes. J Cell Biol (1982) 1.00

Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is osteoprotegerin/osteoclastogenesis inhibitory factor. J Periodontal Res (2001) 0.99

Nuclear Ribosomal DNA as a Probe for Genetic Variability in the Japanese Pear Pathotype of Alternaria alternata. Appl Environ Microbiol (1993) 0.99

Staining of Plasmodium yoelii-infected mouse erythrocytes with the fluorescent dye rhodamine 123. J Protozool (1983) 0.99

Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons. J Neurochem (2001) 0.99

[Renal angiomyolipoma with a tumor thrombus extending into the right atrium--a case report]. Nihon Hinyokika Gakkai Zasshi (1999) 0.98

Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system. Hepatology (2001) 0.98

The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment. Eur J Surg Oncol (2006) 0.98

Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J Biol Chem (1990) 0.98